Lv2
168 积分 2022-04-28 加入
The current and emerging immunotherapy paradigm in small-cell lung cancer
1天前
待确认
The Good Cancer, the Barely Cancer, and the Incurable Cancer
8天前
已完结
The Good Cancer, the Barely Cancer, and the Incurable Cancer
1个月前
已完结
NMOSD and MOGAD: Updates on diagnostic criteria
1个月前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
2个月前
已完结
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
2个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2个月前
已完结
Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
2个月前
已完结
Advancing CAR T-Cell Therapy
4个月前
已完结
皖公网安备34019202002308
